Trastuzumab deruxtecan (T-DXd) in patients with HER2-positive metastatic breast cancer (MBC): Updated survival results from a phase II trial (DESTINY-Breast01) Meeting Abstract
| Authors: | Saura Manich, C.; Modi, S.; Krop, I.; Park, Y. H.; Kim, S. B.; Tamura, K.; André, F.; Iwata, H.; Ito, Y.; Tsurutani, J.; Sohn, J.; Lee, C.; Liu, Y.; Cathcart, J.; Singh, J.; Yamashita, T. |
| Abstract Title: | Trastuzumab deruxtecan (T-DXd) in patients with HER2-positive metastatic breast cancer (MBC): Updated survival results from a phase II trial (DESTINY-Breast01) |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S485 |
| End Page: | S486 |
| Language: | English |
| ACCESSION: | WOS:000700527700258 |
| DOI: | 10.1016/j.annonc.2021.08.562 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 279P -- Source: Wos |
